- Home
- CCCC vs POWW Comparison
CCCC vs POWW Comparison
Compare CCCC & POWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- POWW
- Stock Information
- Founded
- CCCC 2015
- POWW 1990
- Country
- CCCC United States
- POWW United States
- Employees
- CCCC N/A
- POWW N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- POWW Ordnance And Accessories
- Sector
- CCCC Health Care
- POWW Industrials
- Exchange
- CCCC Nasdaq
- POWW Nasdaq
- Market Cap
- CCCC 242.3M
- POWW 209.6M
- IPO Year
- CCCC 2020
- POWW N/A
- Fundamental
- Price
- CCCC $2.44
- POWW $1.72
- Analyst Decision
- CCCC Strong Buy
- POWW Strong Buy
- Analyst Count
- CCCC 4
- POWW 2
- Target Price
- CCCC $8.50
- POWW $2.38
- AVG Volume (30 Days)
- CCCC 1.5M
- POWW 473.7K
- Earning Date
- CCCC 11-06-2025
- POWW 11-10-2025
- Dividend Yield
- CCCC N/A
- POWW N/A
- EPS Growth
- CCCC N/A
- POWW N/A
- EPS
- CCCC N/A
- POWW N/A
- Revenue
- CCCC $30,108,000.00
- POWW $46,632,638.00
- Revenue This Year
- CCCC N/A
- POWW $10.08
- Revenue Next Year
- CCCC N/A
- POWW $0.94
- P/E Ratio
- CCCC N/A
- POWW N/A
- Revenue Growth
- CCCC N/A
- POWW 1343.57
- 52 Week Low
- CCCC $1.09
- POWW $0.95
- 52 Week High
- CCCC $5.10
- POWW $2.14
- Technical
- Relative Strength Index (RSI)
- CCCC 49.92
- POWW 53.05
- Support Level
- CCCC $2.39
- POWW $1.71
- Resistance Level
- CCCC $2.63
- POWW $1.93
- Average True Range (ATR)
- CCCC 0.16
- POWW 0.12
- MACD
- CCCC -0.00
- POWW -0.01
- Stochastic Oscillator
- CCCC 57.63
- POWW 37.50
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
About POWW AMMO Inc.
Outdoor Holding Co Formerly AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.